Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms

(2017) Gemma Modinos et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Adolescent Stress as a Driving Factor for Schizophrenia Development—A Basic Science Perspective

(2017) Felipe V. Gomes et al.   SCHIZOPHRENIA BULLETIN

Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis

(2017) A Egerton et al.   Translational Psychiatry

Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings

(2016) Stefano Marenco et al.   AMERICAN JOURNAL OF PSYCHIATRY

Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis

(2016) Paul Allen et al.   AMERICAN JOURNAL OF PSYCHIATRY

1H-MRS and MEGA-PRESS pulse sequence in the study of balance of inhibitory and excitatory neurotransmitters in the human brain of ultra-high risk of schizophrenia patients

(2016) P. E. Menschikov et al.   Doklady Biochemistry and Biophysics

Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam

(2016) Yijuan Du et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity

(2016) E. C. Zimmerman et al.   JOURNAL OF NEUROSCIENCE

Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression

(2016) Anthony A. Grace   NATURE REVIEWS NEUROSCIENCE

Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy

(2015) Camilo de la Fuente-Sandoval et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study

(2015) L M Rowland et al.   MOLECULAR PSYCHIATRY

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive

(2015) Elias Mouchlianitis et al.   SCHIZOPHRENIA BULLETIN

GABAergic mechanisms of hippocampal hyperactivity in schizophrenia

(2015) Stephan Heckers et al.   SCHIZOPHRENIA RESEARCH

Translating the MAM model of psychosis to humans

(2015) Gemma Modinos et al.   TRENDS IN NEUROSCIENCES

Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia

(2014) David C. Alsop et al.   MAGNETIC RESONANCE IN MEDICINE

Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia

(2014) A D Stan et al.   MOLECULAR PSYCHIATRY

GABA and glutamate in schizophrenia: A 7 T 1H-MRS study

(2014) Anouk Marsman et al.   NeuroImage-Clinical

Increased hippocampal CA1 cerebral blood volume in schizophrenia

(2014) Pratik Talati et al.   NeuroImage-Clinical

Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort

(2013) Alice Egerton et al.   BIOLOGICAL PSYCHIATRY

Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes

(2013) Isabel del Pino et al.   NEURON

Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia

(2013) Yijuan Du et al.   NEUROPSYCHOPHARMACOLOGY

Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy

(2012) Xiangling Mao   ARCHIVES OF GENERAL PSYCHIATRY

The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment

(2012) Oliver D. Howes et al.   ARCHIVES OF GENERAL PSYCHIATRY

Increased Stress-Induced Dopamine Release in Psychosis

(2012) Romina Mizrahi et al.   BIOLOGICAL PSYCHIATRY

Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis

(2012) P. Fusar-Poli et al.   EUROPEAN PSYCHIATRY

Interneuron dysfunction in psychiatric disorders

(2012) Oscar Marín   NATURE REVIEWS NEUROSCIENCE

In Vivo Measurements of Glutamate, GABA, and NAAG in Schizophrenia

(2012) Laura M. Rowland et al.   SCHIZOPHRENIA BULLETIN

To cut a short test even shorter: Reliability and validity of a brief assessment of intellectual ability in Schizophrenia—a control-case family study

(2012) Eva Velthorst et al.   Cognitive Neuropsychiatry

Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study

(2011) Oliver D. Howes et al.   AMERICAN JOURNAL OF PSYCHIATRY

Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study

(2011) Hendrika H. van Hell et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study

(2011) O Howes et al.   MOLECULAR PSYCHIATRY

How Inhibition Shapes Cortical Activity

(2011) Jeffry S. Isaacson et al.   NEURON

A Novel α5GABAAR-Positive Allosteric Modulator Reverses Hyperactivation of the Dopamine System in the MAM Model of Schizophrenia

(2011) Kathryn M Gill et al.   NEUROPSYCHOPHARMACOLOGY

Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI

(2011) Amy Pinkham et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Abnormal Relationship Between Medial Temporal Lobe and Subcortical Dopamine Function in People With an Ultra High Risk for Psychosis

(2011) P. Allen et al.   SCHIZOPHRENIA BULLETIN

Abnormal Frontostriatal Interactions in People With Prodromal Signs of Psychosis

(2010) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Elevated Gamma-Aminobutyric Acid Levels in Chronic Schizophrenia

(2010) Dost Öngür et al.   BIOLOGICAL PSYCHIATRY

Glial and neuronal control of brain blood flow

(2010) David Attwell et al.   NATURE

Resting-State Perfusion in Nonmedicated Schizophrenic Patients: A Continuous Arterial Spin-labeling 3.0-T MR Study

(2010) Lukas Scheef et al.   RADIOLOGY

Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders

(2009) Scott A. Schobel et al.   ARCHIVES OF GENERAL PSYCHIATRY

Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia

(2009) Oliver D. Howes et al.   ARCHIVES OF GENERAL PSYCHIATRY

A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia

(2009) D. J. Lodge et al.   JOURNAL OF NEUROSCIENCE

Amygdalocortical Circuitry in Schizophrenia: From Circuits to Molecules

(2009) Francine M Benes   NEUROPSYCHOPHARMACOLOGY

Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons

(2009) L. Wen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reduction of brain γ-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study

(2009) Naoki Goto et al.   SCHIZOPHRENIA RESEARCH

GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study

(2009) Shin'Ya Tayoshi et al.   SCHIZOPHRENIA RESEARCH

Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields

(2008) Weiying Dai et al.   MAGNETIC RESONANCE IN MEDICINE

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

(2008) John E. Lisman et al.   TRENDS IN NEUROSCIENCES

The Neural Bases of Emotion Regulation: Reappraisal and Suppression of Negative Emotion

(2007) Philippe R. Goldin et al.   BIOLOGICAL PSYCHIATRY